Sodium bisulfite deaminates unmodified cytosines to uracil but does not affect 5-methylcytosines. The bisulfite-treated DNA is then amplified by PCR, during which the 5-methylcytosines are amplified as cytosines and the uracils are amplified as thymines . DNA sequencing can then be used to elucidate the methylation status of a region of interest or an entire genome at single-nucleotide resolution.
PCR amplification of bisulfite-treated DNA requires an enzyme capable of tolerating uracil-containing DNA and high AT targets (conversion of unmodified cytosines to thymines increases the AT ratio of the target DNA). NEB’s EpiMark Taq DNA polymerase has been optimized for successful amplification of bisulfite-treated DNA.
This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB).
While NEB develops and validates its products for various applications, the use of this product may require the buyer to obtain additional third party intellectual property rights for certain applications.
For more information about commercial rights, please contact NEB's Global Business Development team at firstname.lastname@example.org.
This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.